Intel Corp Senti Biosciences, Inc. Transaction History
Intel Corp
- $161 Million
- Q1 2024
A detailed history of Intel Corp transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Intel Corp holds 595,665 shares of SNTI stock, worth $232,309. This represents 0.14% of its overall portfolio holdings.
Number of Shares
595,665
Previous 595,665
-0.0%
Holding current value
$232,309
Previous $393,000
42.49%
% of portfolio
0.14%
Previous 0.19%
Shares
1 transactions
Others Institutions Holding SNTI
# of Institutions
28Shares Held
11MCall Options Held
0Put Options Held
0-
Nea Management Company, LLC Timonium, MD4.43MShares$1.73 Million0.12% of portfolio
-
8 Vc Gp I, LLC Austin, TX2.54MShares$989,6471.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.63MShares$636,0590.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA707KShares$275,7500.0% of portfolio
-
Triatomic Management LP New York, NY311KShares$121,1070.22% of portfolio
About Senti Biosciences, Inc.
- Ticker SNTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,757,100
- Market Cap $17.1M
- Description
- Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...